Collegium Pharmaceutical Inc Capital Reinvestment Ratio
Collegium Pharmaceutical Inc capital reinvestment ratio. Collegium Pharmaceutical Inc (COLL) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($78.44 Million) in capital expenditures ($188.00K). Check COLL capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Collegium Pharmaceutical Inc (2018–2024)
Capital reinvestment ratio of Collegium Pharmaceutical Inc from 2018 to 2024. This chart tracks Collegium Pharmaceutical Inc's Capital Reinvestment Ratio across 7 annual periods. Also explore COLL shareholders equity momentum to track the company's year-over-year net asset growth rate.
Collegium Pharmaceutical Inc Capital Reinvestment Ratio by Year (2018–2024)
Collegium Pharmaceutical Inc capital reinvestment ratio by year from 2018 to 2024. For the full cash flow conversion analysis, see Collegium Pharmaceutical Inc operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $204.98 Million | $1.65 Million | ▲ +380.3% |
| 2023 | 0.00x | $274.75 Million | $461.00K | ▼ -87.1% |
| 2022 | 0.01x | $124.23 Million | $1.62 Million | ▼ -30.4% |
| 2021 | 0.02x | $103.56 Million | $1.94 Million | ▼ -99.5% |
| 2020 | 3.98x | $93.94 Million | $373.77 Million | ▲ +1617.0% |
| 2019 | 0.23x | $27.78 Million | $6.44 Million | ▲ +61.2% |
| 2018 | 0.14x | $169.39 Million | $24.35 Million | — |